FindMyKOL
Clinical trialNCT04161534Active, not recruitingInterventional

KT Tape for Pediatric Clavicle Fractures

NCT04161534 is an interventional trial sponsored by University of Alabama at Birmingham. As of 21 Nov 2026, it is active and no longer recruiting. It studies Clavicle Fracture. The registry lists an enrollment of 50 participants at 1 site in 1 country. The registry lists a start date of 1 Oct 2020 and a primary completion date of 1 Oct 2026.

View the registry record on ClinicalTrials.gov

Key facts

Registry attributes as recorded on the ClinicalTrials.gov study record.

Key facts for NCT04161534
FieldValue
Registry IDNCT04161534
StatusActive not recruiting
Study typeInterventional trial
Lead sponsorUniversity of Alabama at Birmingham
Enrollment50
Registered sites1
Countries1
ConditionsClavicle Fracture
Start1 Oct 2020
Primary completion1 Oct 2026
Study completion1 Oct 2026
Last update posted2 Apr 2026

Registered summary

The lay summary the sponsor registered on ClinicalTrials.gov.

Clavicle fractures in children are mostly managed non-operatively since they have an overall high union rate (95%) and a "good" functional outcome following nonoperative treatment. However, the downside of such a conservative approach is that patients have to live with pain and disability until the fracture heals. To minimize this, fractures are usually immobilized with a sling. There have been no studies looking at clavicle fractures treated with kinesiology (elastic) tape. No adverse effects (skin irritation, redness, etc.) are observed with the application of this tape. Elastic tape has previously been examined regarding muscular advantages rather than for healing fractures. Since this tape should immobilize fractures better than a sling, patients should experience less pain and disability associated with their fracture.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Alabama, United States1 site
  • Children's Hospital of Alabama

    Birmingham

United States, by state

AlaskaAKMaineMEVermontVTNew HampshireNHWashingtonWAMontanaMTNorth DakotaNDMinnesotaMNWisconsinWIMichiganMINew YorkNYMassachusettsMARhode IslandRIOregonORIdahoIDSouth DakotaSDIowaIAIllinoisILIndianaINOhioOHPennsylvaniaPANew JerseyNJConnecticutCTCaliforniaCANevadaNVWyomingWYNebraskaNEMissouriMOKentuckyKYWest VirginiaWVVirginiaVAMarylandMDDelawareDEArizonaAZUtahUTColoradoCOKansasKSArkansasARTennesseeTNNorth CarolinaNCSouth CarolinaSCNew MexicoNMOklahomaOKLouisianaLAMississippiMSAlabama: 1 siteAL1GeorgiaGAHawaiiHITexasTXFloridaFLDistrict of ColumbiaDC
Fewer sitesMore sites

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Questions about NCT04161534

Each answer restates registry values shown on this page.

What is NCT04161534?

NCT04161534 is an interventional trial sponsored by University of Alabama at Birmingham. It studies Clavicle Fracture.

Is NCT04161534 recruiting?

As of 21 Nov 2026, it is active and no longer recruiting.

Who leads NCT04161534?

The registry names Shawn R Gilbert, MD (principal investigator, University of Alabama at Birmingham) as the overall official.

Where does NCT04161534 run?

The registry lists 1 site in 1 country. Every site with a stated country is in one country: United States.

When is NCT04161534 expected to complete?

The registry lists a primary completion date of 1 Oct 2026 and a study completion date of 1 Oct 2026. The sponsor last updated the record on 2 Apr 2026.

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 21 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.